no statement of use filed
on 26 Feb 2024
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
90860823 filed on 02th Aug 2021
Registration Number
N/A
Correspondent Address
Xiomara Triana
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The word(s) YONMIRI has no meaning in a foreign language. Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejectionRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies
No 90860823
No Service/Collective Mark
No 00160182-US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 26th Feb 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 26th Feb 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 25th Jul 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 30th May 2023 | PUBLISHED FOR OPPOSITION |
| 30th May 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th May 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Apr 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 26th Apr 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 26th Apr 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 26th Apr 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
